July 23 (Reuters) -
* INDIAN COS INTRODUCING 22 DRUGS WITHOUT PRIOR APPROVAL OF
THE
NATIONAL PHARMACEUTICAL PRICING AUTHORITY HAVE BEEN ISSUED
NOTICES - GOVERNMENT STATEMENT
* NPPA HAS SO FAR ISSUED DEMAND NOTICES FOR AN AMOUNT OF
1.01
BILLION RUPEES AGAINST DEFAULTING COMPANIES - GOVERNMENT
STATEMENT
* INDIAN COMPANIES ISSUED NOTICES BY NPPA INCLUDE ALEMBIC
PHARMA,
BIOCON LTD, CIPLA, LUPIN, WOCKHARDT, SANOFI INDIA, DR REDDYS
LABS - GOVERNMENT
Source text for Eikon: (http://bit.ly/2yfGeIB)
((bangalore.newsroom@thomsonreuters.com;))